A detailed history of Oliver Lagore Vanvalin Investment Group transactions in Pfizer Inc stock. As of the latest transaction made, Oliver Lagore Vanvalin Investment Group holds 170 shares of PFE stock, worth $4,346. This represents 0.0% of its overall portfolio holdings.

Number of Shares
170
Previous 220 22.73%
Holding current value
$4,346
Previous $6,000 33.33%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$27.7 - $31.39 $1,385 - $1,569
-50 Reduced 22.73%
170 $4,000
Q2 2024

Aug 15, 2024

BUY
$25.26 - $29.6 $1,263 - $1,480
50 Added 29.41%
220 $6,000
Q1 2024

May 15, 2024

SELL
$25.89 - $29.73 $724 - $832
-28 Reduced 14.14%
170 $4,000
Q4 2023

Jan 31, 2024

SELL
$26.13 - $33.94 $3,605 - $4,683
-138 Reduced 41.07%
198 $5,000
Q3 2023

Nov 09, 2023

SELL
$32.09 - $37.51 $9,819 - $11,478
-306 Reduced 47.66%
336 $11,000
Q2 2023

Aug 08, 2023

SELL
$36.12 - $41.79 $5,887 - $6,811
-163 Reduced 20.25%
642 $23,000
Q1 2023

Jun 20, 2023

SELL
$39.39 - $51.28 $4,293 - $5,589
-109 Reduced 11.93%
805 $32,000
Q4 2022

Mar 02, 2023

SELL
$41.75 - $54.5 $8,224 - $10,736
-197 Reduced 17.73%
914 $46,000
Q3 2022

Nov 15, 2022

BUY
$43.76 - $53.42 $3,719 - $4,540
85 Added 8.28%
1,111 $49,000
Q2 2022

Aug 16, 2022

SELL
$46.53 - $55.17 $10,748 - $12,744
-231 Reduced 18.38%
1,026 $54,000
Q1 2022

Jun 17, 2022

SELL
$45.75 - $56.69 $4.07 Million - $5.04 Million
-88,863 Reduced 98.61%
1,257 $64,000
Q4 2021

Mar 23, 2022

BUY
$41.32 - $61.25 $3.72 Million - $5.52 Million
90,120 New
90,120 $5.32 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $144B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Oliver Lagore Vanvalin Investment Group Portfolio

Follow Oliver Lagore Vanvalin Investment Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oliver Lagore Vanvalin Investment Group, based on Form 13F filings with the SEC.

News

Stay updated on Oliver Lagore Vanvalin Investment Group with notifications on news.